Dyspnoea in obesity

P. Lotti, S. Bertini, F. Bottino, R. Bianchi, S. Mirblook, F. Tesi, C. M. Rotella, R. Duranti, G. Scano (Firenze, Pozzolatico, Firenze, Italy)

Source: Annual Congress 2001 - Respiratory physiology and pulmonary function tests: an animal and human pot-pourri
Session: Respiratory physiology and pulmonary function tests: an animal and human pot-pourri
Session type: Thematic Poster Session
Number: 1763
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Lotti, S. Bertini, F. Bottino, R. Bianchi, S. Mirblook, F. Tesi, C. M. Rotella, R. Duranti, G. Scano (Firenze, Pozzolatico, Firenze, Italy). Dyspnoea in obesity. Eur Respir J 2001; 16: Suppl. 31, 1763

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exertional dyspnoea in obesity
Source: Eur Respir Rev 2016; 25: 487-495
Year: 2016



Dyspnoea
Source: Research Seminar 2007 - The limits to exercise in COPD: new insights from new methods
Year: 2007


Obesity and asthma severity
Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Year: 2010


Asthma and obesity
Source: International Congress 2016 – Obesity and respiratory diseases
Year: 2016


Asthma and obesity
Source: Eur Respir J 2006; 28: Suppl. 50, 322s
Year: 2006

Dyspnoea in relation to obesity in general practice
Source: Eur Respir J 2004; 24: Suppl. 48, 404s
Year: 2004

Obesity hypoventilation syndrome: much more than overweight
Source: Annual Congress 2008 - The obese: a pulmonary patient
Year: 2008


Dyspnea in morbid obesity: relationships with inspiratory muscle performance
Source: Eur Respir J 2004; 24: Suppl. 48, 337s
Year: 2004

Effects of OSA on metabolic dysfunction in adolescents - is OSA relevant for adolescent obesity?
Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options
Year: 2009


Anthropometric markers of adiposity and visceral adiposity index (VAI) in patients with OSA
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013


Obesity and COPD
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010

Frequency and predictors of obesity hypoventilation syndrome in morbidly obese (BMI ≥40) patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013


Protective cardiovascular effect of sleep apnea severity in obesity hypoventilation syndrome
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016


Prevalence of obesity hypoventilation syndrome in OSA patients in the UAE
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013


Impacts of long-term CPAP therapy on fatty liver in male OSA patients with abdominal obesity
Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions
Year: 2014

Clinical predictors of obesity hypoventilation syndrome in morbidly obese subjects with obstructive sleep apnoea
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015

Obesity and asthma symptoms in children
Source: Annual Congress 2012 - Predicting and observing paediatric allergic disease
Year: 2012


Grading obesity hypoventilation syndrome severity
Source: Eur Respir J 2008; 32: 817-818
Year: 2008


Prevalence and diagnosis of obesity hypoventilation syndrome (OHS) in ambulatory obese patients
Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea
Year: 2016


Covid-19 and obesity
Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19
Year: 2021